This topic contains a solution. Click here to go to the answer

Author Question: A patient with HIV and mucocutaneous HSV is being treated with foscarnet after failing treatment ... (Read 24 times)

erika

  • Hero Member
  • *****
  • Posts: 522
A patient with HIV and mucocutaneous HSV is being treated with foscarnet after failing treatment with acyclovir. After 2 weeks, the patient's dose is increased to 90 mg/kg over 2 hours from 40 mg/kg over 1 hour.
 
  The patient reports numbness in the extremities and perioral tingling. What will the nurse do? a. Notify the provider and request an order for a serum calcium level.
  b. Notify the provider of potential foscarnet overdose.
  c. Request an order for a creatinine clearance level.
  d. Request an order of IV saline to be given before the next dose.

Question 2

A nurse provides teaching for a patient with cytomegalovirus (CMV) retinitis who will receive the ganciclovir ocular implant Vitrasert. Which statement by the patient indicates a need for further teaching?
 
  a. My vision may be blurred for 2 to 4 weeks after receiving the implant.
  b. Surgical placement of the implant is an outpatient procedure.
  c. The implant will remain in place perma-nently.
  d. The implant will slow progression of CMV retinitis.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

komodo7

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

A
Foscarnet frequently causes hypocalcemia and other electrolyte and mineral imbalances. Pares-thesias, numbness in the extremities, and perioral tingling can indicate hypocalcemia, so a calcium level should be drawn. These are not signs of foscarnet overdose. Nephrotoxicity may occur, but these are not signs of renal complications, so a creatinine clearance is not indicated. If nephrotoxicity occurs, prehydration with IV saline is indicated to reduce the risk of renal injury.

Answer to Question 2

C
Ganciclovir ocular implants must be replaced every 5 to 8 months and do not remain in place permanently. It is correct that vision may be blurred for 2 to 4 weeks after placement of the im-plant, that placement is an outpatient procedure, and that the implant will slow progression of CMV retinitis.




erika

  • Member
  • Posts: 522
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


Chelseyj.hasty

  • Member
  • Posts: 319
Reply 3 on: Yesterday
Gracias!

 

Did you know?

The eye muscles are the most active muscles in the whole body. The external muscles that move the eyes are the strongest muscles in the human body for the job they have to do. They are 100 times more powerful than they need to be.

Did you know?

Methicillin-resistant Staphylococcus aureus or MRSA was discovered in 1961 in the United Kingdom. It if often referred to as a superbug. MRSA infections cause more deaths in the United States every year than AIDS.

Methicilli ...
Did you know?

All patients with hyperparathyroidism will develop osteoporosis. The parathyroid glands maintain blood calcium within the normal range. All patients with this disease will continue to lose calcium from their bones every day, and there is no way to prevent the development of osteoporosis as a result.

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

For a complete list of videos, visit our video library